Replies to post #358 on Keryx Biopharmaceuticals Inc fka KERX

[imiloa]

mazmania, i've only been following KERX since last Fall. The recent annual report is a good place to start:

http://biz.yahoo.com/e/090331/kerx10-k.html

According to it, they have two projects in Phase 2:

-- Zerenex- Phase 2 - treatment of hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease, or ESRD.

-- KRX-0401 - Phase 2 -- for multiple tumor types

Another, Sulonex, was Phase 3/4 but was terminated.

Other highlights include no debt, and decent cash in bank, more than market cap at last report. Though the annual burn rate has likely cut into that in the months since last update.

Given the reduced share price (amid market crash), I've been expected KERX to get acquired by a larger firm for a decent premium on the current market cap. Time will tell...